Long intergenic non-protein coding RNA 824 (LINC00824)

Long intergenic non-protein coding RNA 824 (LINC00824) is a member of the long intergenic non-coding RNA (lincRNA) family, a type of long non-coding RNA (lncRNA) longer than 200 nucleotides and not translated into protein[1][5]. LINC00824 does not code for a protein and is thought to modulate gene regulation at the transcriptional or epigenetic level, which is a common function for lincRNAs, though its precise biological mechanisms remain unclear[1][5]. Genetic variants within LINC00824 have been statistically associated with susceptibility or protection against certain diseases, including chronic obstructive pulmonary disease[2]. LINC00824 also appears in panels for genetic risk assessment in diabetes and can be detected in molecular profiling studies, but there is no evidence it is a direct drug target, nor is there any well-established mechanism of drug action involving LINC00824[4][2][1]. No widely recognized drugs, safety concerns, or clinical therapies are known to directly target LINC00824. Note: - LINC00824 is not a protein, receptor, enzyme, or typical pharmacological target, but an RNA locus whose presence, absence, or sequence variation may have regulatory or biomarker significance[1][5]. - There is no evidence for any clinically approved drugs acting on or via LINC00824, nor data on associated safety concerns or drug mechanisms. - Its disease-relevance is currently limited to potential as a genetic or molecular biomarker, not as a direct therapeutic target[2][4].

Other names

LINC00824